Starlyte Bio
Next generation diagnostics
Starlyte Bio
Next generation diagnostics
Our Mission
We aim to push diagnostic technology into the next generation by illuminating the whole picture across diseases using the full chromatin structure that defines the disease state. This will provide insights into health and disease like never before.
Applications of our Analytical platform
Predicting Response to Immunotherapy
Using the StarLyte Bio approach you can determine more accurately which patients will benefit from immunotherapy and for how long those benefits will last. Saving time, money, and improving patient experience.
Companion Diagnostics
We can partner with you to develop companion diagnostics for established therapies and better select patients for clinical trials of novel therapies.
In-Depth Analysis of Failed Trials
"Why did the trial fail" can be a difficult question to answer. StarLyte Bio can provide new insight into answer that question in both pre-clinical and clinical trials.
About Us
Peter Kabos, MD
Srinivas Ramachandran, PhD
Srinivas Ramachandran, PhD
Dr. Peter Kabos is a medical oncologist with expertise in treatment resistance, tumor microenvironments, breast cancer research, and cfDNA method development.
Srinivas Ramachandran, PhD
Srinivas Ramachandran, PhD
Srinivas Ramachandran, PhD
Dr. Srinivas Ramachandran is a chromatin biologist with expertise in chromatin dynamics, genomics, and cfDNA method development.